Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

1995-08-31

Study Completion Date

2000-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients are exposed to infectious agents regularly, regardless of their immunologic status. Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors, skin test (i.e. PPD), or immunologic parameters. A quantitative and specific method that is non-invasive, such as quantitative PCR, would be desirable to more precisely define those who would benefit from prophylaxis. Similarly, when patients develop disease and are being treated, quantitative, non-invasive techniques are needed to assess response to therapy. This project is designed to develop and test quantitative tests using blood, urine, or sputum samples.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Role of Multiplex PCR in CAP

NCT06097117

Community-acquired Pneumonia

UNKNOWN

Community-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.

NCT06259110

Community-acquired Pneumonia

NOT_YET_RECRUITING

Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments

NCT05638932

COVID-19

COMPLETED

Immunophenotyping Assessment in a COVID-19 Cohort

NCT04378777

Coronavirus Disease 2019 (COVID-19) SARS-CoV-2

COMPLETED

Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19

NCT04373148

Coronavirus

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients are exposed to infectious agents regularly, regardless of their immunologic status. Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors, skin test (i.e. PPD), or immunologic parameters. A quantitative and specific method that is non-invasive, such as quantitative PCR, would be desirable to more precisely define those who would benefit from prophylaxis. Similarly, when patients develop disease and are being treated, quantitative, non-invasive techniques are needed to assess response to therapy. This project is designed to develop and test quantitative tests using blood, urine, or sputum samples.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Communicable Diseases Opportunistic Infections

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients older than 18 years of age.

Ability to give informed consent.

No medical contraindication to phlebotomy.

Epidemiologically at risk for tuberculosis or for an opportunistic infection.

Patients who can identify a responsible health care provider as someone willing to provide clinical information and to receive medically important information.

Eligible Sex

ALL

Accepts Healthy Volunteers

No